Cordis Corporation Launches INCRAFT® AAA Stent Graft System For Treatment Of Abdominal Aortic Aneurysms (AAA)

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

FREMONT, Calif.--(BUSINESS WIRE)--Cordis Corporation announced today the launch of its INCRAFT® AAA Stent Graft System (INCRAFT® System), an ultra-low profile device for use during endovascular aneurysm repair (EVAR) for patients suffering from infrarenal abdominal aortic aneurysms (AAA). The INCRAFT® System is cleared for use and now available in Europe and Canada. This device is an advancement in the EVAR field and provides a new option for patients and physicians seeking a less invasive treatment approach for AAA.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC